Co-occurring addiction and mental disorders
... The present study investigated whether simultaneous treatment of social phobia and alcoholism, compared with treatment of alcoholism alone, improved alcohol use and social anxiety for clients with dual diagnoses of social anxiety disorder and alcohol dependence. METHODS: The design was a two-group, ...
... The present study investigated whether simultaneous treatment of social phobia and alcoholism, compared with treatment of alcoholism alone, improved alcohol use and social anxiety for clients with dual diagnoses of social anxiety disorder and alcohol dependence. METHODS: The design was a two-group, ...
Initiating Depot Antipsychotics
... Joyce is taking an approximate equivalent haloperidol dose of 10 mg/day. The recommended conversion formula provided for converting from oral to depot haloperidol is: Haloperidol oral dose x 10-20 times = haloperidol decanoate dose every 4 weeks Using this conversion table the starting dose for halo ...
... Joyce is taking an approximate equivalent haloperidol dose of 10 mg/day. The recommended conversion formula provided for converting from oral to depot haloperidol is: Haloperidol oral dose x 10-20 times = haloperidol decanoate dose every 4 weeks Using this conversion table the starting dose for halo ...
teveten-hct
... 100 mg to 800 mg dose range. The mean terminal elimination half-life of eprosartan following multiple oral doses of 600 mg was approximately 20 hours. Eprosartan does not significantly accumulate with chronic use. Hydrochlorothiazide: When hydrochlorothiazide plasma levels have been followed for at ...
... 100 mg to 800 mg dose range. The mean terminal elimination half-life of eprosartan following multiple oral doses of 600 mg was approximately 20 hours. Eprosartan does not significantly accumulate with chronic use. Hydrochlorothiazide: When hydrochlorothiazide plasma levels have been followed for at ...
the management of hypertension
... initiate appropriate treatment which then can be continued by the practitioner in association with the clinic. Multiple readings of the blood pressure are necessary but time-consuming and the medical staff may be inadequate for the purpose. In such cases there is no reason why a technician or nurse ...
... initiate appropriate treatment which then can be continued by the practitioner in association with the clinic. Multiple readings of the blood pressure are necessary but time-consuming and the medical staff may be inadequate for the purpose. In such cases there is no reason why a technician or nurse ...
& ● Memorandum
... Leardini, M. Passeri and M. Cucinotta D., conducted their study on 150 patients, who had been suffering of mono- or hi-lateral hip or knee joint osteoarthritis, at five clinical centers as a controlled, double blind and randomized study. The patients were allocated to either SAMe or ibuprofen treatm ...
... Leardini, M. Passeri and M. Cucinotta D., conducted their study on 150 patients, who had been suffering of mono- or hi-lateral hip or knee joint osteoarthritis, at five clinical centers as a controlled, double blind and randomized study. The patients were allocated to either SAMe or ibuprofen treatm ...
Antibiotics - SeattleCloud
... neuritis (reduced with 10 mg/day of Pyridoxine). Administration: take on an empty stomach. Used in pregnant women with TB. Concomitant administration of Pyridoxine is necessary. Contraindications: liver disease and hypersensitivity. ...
... neuritis (reduced with 10 mg/day of Pyridoxine). Administration: take on an empty stomach. Used in pregnant women with TB. Concomitant administration of Pyridoxine is necessary. Contraindications: liver disease and hypersensitivity. ...
see Section 3.1 - Doncaster and Bassetlaw Hospitals NHS
... The aim of asthma management is control of the disease. Complete control of asthma is defined as: no daytime symptoms no night-time awakening due to asthma no need for rescue medication no exacerbations no limitations on activity including exercise normal lung function (in practical term ...
... The aim of asthma management is control of the disease. Complete control of asthma is defined as: no daytime symptoms no night-time awakening due to asthma no need for rescue medication no exacerbations no limitations on activity including exercise normal lung function (in practical term ...
Pharmacist Activist T
... who are trying to describe the program and the patients who expect to benefit from it. Wal-Mart’s program only covers a small fraction of the generic medications that are available (the lowest-priced ones) and it should have made that clear at the outset rather than trying to create the impression th ...
... who are trying to describe the program and the patients who expect to benefit from it. Wal-Mart’s program only covers a small fraction of the generic medications that are available (the lowest-priced ones) and it should have made that clear at the outset rather than trying to create the impression th ...
Brief Summary of Full Prescribing Information. WARNING
... protein-bound particles to rats on gestation days 7 to 17 at doses of 6 mg/m2 (approximately 2% of the daily maximum recommended human dose on a mg/m2 basis) caused embryo- and fetotoxicity, as indicated by intrauterine mortality, increased resorptions (up to 5-fold), reduced numbers of litters and ...
... protein-bound particles to rats on gestation days 7 to 17 at doses of 6 mg/m2 (approximately 2% of the daily maximum recommended human dose on a mg/m2 basis) caused embryo- and fetotoxicity, as indicated by intrauterine mortality, increased resorptions (up to 5-fold), reduced numbers of litters and ...
![women in placebo [see Warnings and Precautions (5.1)].](http://s1.studyres.com/store/data/000496143_1-b5cb8421d88ee2428d376ba2f96b6b45-300x300.png)
women in placebo [see Warnings and Precautions (5.1)].
... Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. ...
... Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. ...
Nature Made TripleFlex
... •Glucosamine and chondroitin have been shown to enhance the protective response of chondrocytes, the cells that form cartilage, and may improve cartilage health.[2] •Three clinical trials reported that MSM at doses of 2250 mg/day[3] and 1500 mg/day[4] and 6000 mg/day[5] reduced joint discomfort. •Fo ...
... •Glucosamine and chondroitin have been shown to enhance the protective response of chondrocytes, the cells that form cartilage, and may improve cartilage health.[2] •Three clinical trials reported that MSM at doses of 2250 mg/day[3] and 1500 mg/day[4] and 6000 mg/day[5] reduced joint discomfort. •Fo ...
Selecting Topical and Systemic Agents for Recurrent Aphthous
... pentoxifylline appears to be due to the inhibition of tumor necrosis factor and other inflammatory cytokines.13,14 Several small uncontrolled trials utilizing pentoxifylline, 400 mg 3 times daily, have reported excellent results, some with long-term benefits.15,16 We have treated a significant num ...
... pentoxifylline appears to be due to the inhibition of tumor necrosis factor and other inflammatory cytokines.13,14 Several small uncontrolled trials utilizing pentoxifylline, 400 mg 3 times daily, have reported excellent results, some with long-term benefits.15,16 We have treated a significant num ...
Itraconazole
... Absorption is impaired when gastric acidity is reduced. In patients receiving acid neutralizing medicines (e.g. aluminium hydroxide), these should be administered at least 2 hours after the intake of Itraconazole. The drug should be administered after a full meal. Rarely, cases of hepatitis and jaun ...
... Absorption is impaired when gastric acidity is reduced. In patients receiving acid neutralizing medicines (e.g. aluminium hydroxide), these should be administered at least 2 hours after the intake of Itraconazole. The drug should be administered after a full meal. Rarely, cases of hepatitis and jaun ...
v. designs of exposure
... Many drugs thought to be of potential value in treating human disease are introduced into development based on knowledge of in vitro receptor binding properties and identified pharmacodynamic effects in animals. Apart from describing the tolerability and PK of a drug in humans, Phase 1 and 2 studies ...
... Many drugs thought to be of potential value in treating human disease are introduced into development based on knowledge of in vitro receptor binding properties and identified pharmacodynamic effects in animals. Apart from describing the tolerability and PK of a drug in humans, Phase 1 and 2 studies ...
Change in Glomerular Filtration Rate and Renal Biomarkers in
... reduced viral titers of HCV infected livers. GalNAc conjugation affords preferential targeting of RG-101 to hepatocytes, by high affinity binding to highly expressed asialoglycoprotein receptors on hepatocytes that are responsible for removal of target glycoproteins from the systemic circulation. On ...
... reduced viral titers of HCV infected livers. GalNAc conjugation affords preferential targeting of RG-101 to hepatocytes, by high affinity binding to highly expressed asialoglycoprotein receptors on hepatocytes that are responsible for removal of target glycoproteins from the systemic circulation. On ...
APO-DOXAZOSIN Doxazosin 1mg, 2mg and 4mg Tablets
... Doxazosin Mesylate equivalent to Doxazosin 1mg, 2mg & 4mg Tablets therapy has not been established. Elevations of plasma renin activity and tachycardia were seen infrequently in sustained therapy. Doxazosin produces favourable effects on blood lipids, with significant increase in the HDL/total chole ...
... Doxazosin Mesylate equivalent to Doxazosin 1mg, 2mg & 4mg Tablets therapy has not been established. Elevations of plasma renin activity and tachycardia were seen infrequently in sustained therapy. Doxazosin produces favourable effects on blood lipids, with significant increase in the HDL/total chole ...
Dr. Zsolt Petke
... 68,8% of the participants in the research were male and 31,3 were female. Most of them, 75% live in major cities, 10% in towns and 7,5% in villages. Cities with a population of 100.000 or more were considered major, between 10.000 and 100.000 were considered towns, and with population under 10.000 w ...
... 68,8% of the participants in the research were male and 31,3 were female. Most of them, 75% live in major cities, 10% in towns and 7,5% in villages. Cities with a population of 100.000 or more were considered major, between 10.000 and 100.000 were considered towns, and with population under 10.000 w ...
... respond better to treatment, and to survive longer, than those with extensive fibrosis on biopsy [5, 6]. This may be true for groups of patients, but not for individual cases. I have seen patients with widespread fibrosis on biopsy, who have responded well to treatment, and, conversely' have also ob ...
united states securities and exchange commission - corporate
... This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding the encouraging clinical data of BGB-A317, the potential implications of these data for the future devel ...
... This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding the encouraging clinical data of BGB-A317, the potential implications of these data for the future devel ...
FORM 6-K - corporate
... Acute Asthma Symptoms or Deteriorating Disease: CINQAIR should not be used to treat acute asthma symptoms or acute exacerbations. Do not use CINQAIR to treat acute bronchospasm or status asthmaticus. Patients should seek medical advice if their asthma remains uncontrolled or worsens after initiation ...
... Acute Asthma Symptoms or Deteriorating Disease: CINQAIR should not be used to treat acute asthma symptoms or acute exacerbations. Do not use CINQAIR to treat acute bronchospasm or status asthmaticus. Patients should seek medical advice if their asthma remains uncontrolled or worsens after initiation ...
more
... It is a fungstatic drug ,it dose not kill the fungus already established, it prevent the infection of new keratin so that the duration of treatment is governed by time that it take for infected keratin to be shed(4-6wks for hair and skin 6 months for finger nail and I year for toenail infections). C ...
... It is a fungstatic drug ,it dose not kill the fungus already established, it prevent the infection of new keratin so that the duration of treatment is governed by time that it take for infected keratin to be shed(4-6wks for hair and skin 6 months for finger nail and I year for toenail infections). C ...
Dermatology brochure - Medical Instill Technologies, Inc
... marketing and competitive advantages, these technologies add significant value to topical formulations. MedInstill is a research and development enterprise focused on innovative pharmaceutical manufacturing and drug delivery technologies. MedInstill commercializes its technologies and devices throug ...
... marketing and competitive advantages, these technologies add significant value to topical formulations. MedInstill is a research and development enterprise focused on innovative pharmaceutical manufacturing and drug delivery technologies. MedInstill commercializes its technologies and devices throug ...
Cardiovascular Drug Agents
... problems of congestive heart failure (CHF). In patients with congestive heart failure occurs when the ejection fraction compared with the total amount of blood in the ventricle is decreased. ...
... problems of congestive heart failure (CHF). In patients with congestive heart failure occurs when the ejection fraction compared with the total amount of blood in the ventricle is decreased. ...
Bilastine
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.